Health score, price, valuation, risk signals, and key metrics at a glance.
Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering and agriculture, smart street lighting, renewable energy, electric vehicle supply equipment, industrial wearables and equipment, commercial building automation, consumer electronics, asset tracking, and medical instrumentation; and commercial IoT applications, including smart buildings and lighting, access controls, asset tracking, electronic shelf labels, theft protection, power tools, and enterprise access points. The company's smart home applications comprise smart home cameras, locks, gateways, residential lighting, window shades/blinds, heating, ventilation, air conditioning, switches, smoke/CO detectors, sensors, and home security panels; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking, as well as provides wireless microcontrollers products. It sells its products through its direct sales force, as well as a network of independent sales representatives and distributors. The company was founded in 1996 and is headquartered in Austin, Texas.
Grade capped at D — Interest coverage below 1× (-43.2x) — earnings cannot cover interest. Strongest: Growth (21/25); weakest: Cash & Earnings Quality (4/25).
Today's multiple positioned against its own trailing range — a visual premium/discount check.
Currently above its 9-quarter median.
Currently above its 20-quarter median.
Data-driven signals worth keeping an eye on across the last 8 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
Free cash flow has been negative in 4 of the last 8 quarters — earnings are not translating to cash.
as of July 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Currently above its 20-quarter median.
4 of the last 8 quarters had negative FCF — inconsistent cash generation raises sustainability concerns.
Shares outstanding rose 2.8% — mild dilution. Compare to earnings growth to assess the net per-share impact.